Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Infrared Cameras Holdings Inc | Daniel M. Friedberg | Director, Ten Percent Owner, See Footnotes | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 21,905,300 | 27,507,114 | - | - | Warrants to purchase common stock | |
| Infrared Cameras Holdings Inc | Daniel M. Friedberg | Director, Ten Percent Owner, See Footnotes | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 10,952,650 | 21,747,896 | - | - | Common stock, $0.0001 par value per share | |
| Infrared Cameras Holdings Inc | Daniel M. Friedberg | Director, Ten Percent Owner, See Footnotes | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 5,353,632 | 6,722,710 | - | - | Warrants to purchase common stock | |
| AMKOR Tech Inc | James J. Kim | Ten Percent Owner, Member of 10% owner group (6) | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Dec 2025 | 3,244,594 | 61,645 (0%) | 1% | 0 | Common Stock | |
| AMKOR Tech Inc | Susan Y. Kim | Director, Ten Percent Owner, Member of 10% owner group (8) | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Dec 2025 | 3,244,594 | 3,244,594 (1%) | 1% | 0 | Common Stock | |
| AMKOR Tech Inc | Agnes C. Kim | Member of 10% owner group (4) | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Dec 2025 | 3,244,594 | 10,012,355 (4%) | 1% | 0 | Common Stock | |
| Cipher Mining Inc | Rodney Tyler Page | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 3,057,066 | 3,057,066 | - | - | Performance Stock Units | |
| Asana Inc (Class A) | Justin Rosenstein | Director | 19 Dec 2025 | 3,000,000 | 7,716,532 | - | - | Class B Common Stock | ||
| Asana Inc (Class A) | Justin Rosenstein | Director | 19 Dec 2025 | 3,000,000 | 3,210,398 | - | 0 | Class A Common Stock | ||
| Infrared Cameras Holdings Inc | Daniel M. Friedberg | Director, Ten Percent Owner, See Footnotes | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 2,676,816 | 4,843,223 | - | - | Common stock, $0.0001 par value per share | |
| AMKOR Tech Inc | James J. Kim | Ten Percent Owner, Member of 10% owner group (6) | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Dec 2025 | 2,538,000 | 0 (0%) | 1% | 0 | Common Stock | |
| AMKOR Tech Inc | Susan Y. Kim | Director, Ten Percent Owner, Member of 10% owner group (8) | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Dec 2025 | 2,538,000 | 2,538,000 (1%) | 1% | 0 | Common Stock | |
| AMKOR Tech Inc | Agnes C. Kim | Member of 10% owner group (4) | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Dec 2025 | 2,538,000 | 0 (0%) | 1% | 0 | Common Stock | |
| Intuitive Machines Inc (Class A) | Stephen Altemus | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 1,958,593 | 13,342,213 | - | - | Common Units | |
| Intuitive Machines Inc (Class A) | Stephen Altemus | Director, Chief Executive Officer, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Dec 2025 | 1,958,593 | 13,342,213 | - | - | Class C Common Stock | |
| Intuitive Machines Inc (Class A) | Stephen Altemus | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 1,958,593 | 2,984,995 | - | - | Class A Common Stock | |
| Eventbrite Inc (Class A) | Julia Hartz | Director, CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 1,632,688 | 3,216,331 (5%) | 2% | 0 | Class A Common Stock | |
| Eventbrite Inc (Class A) | Julia Hartz | Director, CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.43 per share. | 19 Dec 2025 | 1,413,175 | 1,803,156 (2%) | 2% | 4.4 | 6,260,365 | Class A Common Stock |
| Intuitive Machines Inc (Class A) | Stephen Altemus | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 16.00 per share. | 19 Dec 2025 | 1,200,567 | 1,144,661 | - | 16.0 | 19,207,391 | Class A Common Stock |
| Eastman Kodak Co. | James V. Continenza | Director, Executive Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.03 per share. | 19 Dec 2025 | 1,150,000 | 3,205,944 (7%) | 2% | 3.0 | 3,484,500 | Common Stock, par value $.01 |
| Eastman Kodak Co. | James V. Continenza | Director, Executive Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 1,150,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Cipher Mining Inc | Rodney Tyler Page | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 1,019,022 | 8,821,573 | - | 0 | Common Stock | |
| Cipher Mining Inc | Rodney Tyler Page | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 1,019,022 | 2,038,044 | - | - | Performance Stock Units | |
| Nexalin Tech Inc | Mark White | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 1,000,000 | 2,387,024 | - | - | Stock Option (right to buy)* | |
| Nexalin Tech Inc | David Owens | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 1,000,000 | 2,484,809 | - | - | Stock Option (right to buy)* | |
| Eastman Kodak Co. | James V. Continenza | Director, Executive Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 981,707 | 0 | - | - | Stock Option (Right to Buy) | |
| Eastman Kodak Co. | James V. Continenza | Director, Executive Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.03 per share. | 19 Dec 2025 | 981,707 | 3,481,422 (8%) | 2% | 3.0 | 2,974,572 | Common Stock, par value $.01 |
| Cipher Mining Inc | Patrick Kelly | Co-President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 917,120 | 917,120 | - | - | Performance Stock Units | |
| Cipher Mining Inc | William Iwaschuk | Co-President and CLO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 917,120 | 917,120 | - | - | Performance Stock Units | |
| Conoco Phillips | Ryan M. Lance | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 819,900 | 0 | - | - | Stock Options (right to Buy) | |
| Conoco Phillips | Ryan M. Lance | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.13 per share. | 19 Dec 2025 | 819,900 | 826,680 (0%) | 0% | 33.1 | 27,159,188 | Common Stock |
| Eastman Kodak Co. | James V. Continenza | Director, Executive Chairman and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.33 per share. | 19 Dec 2025 | 706,229 | 2,499,715 (5%) | 1% | 8.3 | 5,882,888 | Common Stock, par value $.01 |
| Asana Inc (Class A) | Justin Rosenstein | Director | 19 Dec 2025 | 665,000 | 7,051,532 | - | - | Class B Common Stock | ||
| Asana Inc (Class A) | Justin Rosenstein | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Dec 2025 | 665,000 | 3,210,398 | - | 0 | Class A Common Stock | |
| Asana Inc (Class A) | Justin Rosenstein | Director | 19 Dec 2025 | 665,000 | 3,875,398 | - | 0 | Class A Common Stock | ||
| Intuitive Machines Inc (Class A) | Stephen Altemus | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 15.17 per share. | 19 Dec 2025 | 639,767 | 2,345,228 | - | 15.2 | 9,704,690 | Class A Common Stock |
| Eastman Kodak Co. | James V. Continenza | Director, Executive Chairman and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.33 per share. | 19 Dec 2025 | 602,878 | 2,878,544 (6%) | 1% | 8.3 | 5,021,974 | Common Stock, par value $.01 |
| Skillz Inc (Class A) | Andrew Paradise | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 571,429 | 571,429 | - | - | CEO Performance Stock Unit | |
| SiriusPoint Ltd | Scott Egan | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 19 Dec 2025 | 545,083 | 545,083 (0%) | 0% | 0 | Common Shares | |
| SiriusPoint Ltd | Scott Egan | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 19 Dec 2025 | 545,083 | 239,083 (0%) | 0% | 0 | Common Shares | |
| Helmerich & Payne Inc | John W. Lindsay | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Dec 2025 | 526,123 | 210,385 (0%) | 0% | 0 | Common Stock | |
| Cipher Mining Inc | Rodney Tyler Page | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.21 per share. | 19 Dec 2025 | 520,211 | 8,301,362 | - | 16.2 | 8,432,620 | Common Stock |
| Conoco Phillips | Ryan M. Lance | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 92.50 per share. | 19 Dec 2025 | 500,708 | 325,972 (0%) | 0% | 92.5 | 46,315,490 | Common Stock |
| Rush Street Interactive Inc (Class A) | Neil Bluhm | Director, Executive Chairman, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Dec 2025 | 500,000 | 106,911,780 | - | - | Class A Common Units of Rush Street Interactive, L.P. | |
| Rush Street Interactive Inc (Class A) | Neil Bluhm | Director, Executive Chairman, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Dec 2025 | 500,000 | 106,911,780 | - | 0 | Class V Voting Stock | |
| Flora Growth Corp | Daniel Reis-Faria | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 471,208 | 471,208 | - | - | Employee Stock Option (Right to Buy) | |
| Flora Growth Corp | Michael Heinrich | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 471,208 | 471,208 | - | - | Director Stock Option (Right to Buy) | |
| Skillz Inc (Class A) | Andrew Paradise | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 362,304 | 452,889 | - | - | Restricted Stock Units | |
| Skillz Inc (Class A) | Andrew Paradise | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 362,304 | 1,439,726 | - | 0 | Class A common stock | |
| Gitlab Inc (Class A) | Matthew Jacobson | Director | Sale of securities on an exchange or to another person at price $ 38.08 per share. | 19 Dec 2025 | 334,827 | 0 | - | 38.1 | 12,749,844 | Class A Common Stock |
| Eventbrite Inc (Class A) | Anand Gandhi | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.43 per share. | 19 Dec 2025 | 320,073 | 913,556 (1%) | 0% | 4.4 | 1,417,923 | Class A Common Stock |
| Cipher Mining Inc | Patrick Kelly | Co-President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 305,707 | 611,413 | - | - | Performance Stock Units | |
| Cipher Mining Inc | Patrick Kelly | Co-President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 305,707 | 1,704,276 | - | 0 | Common Stock | |
| Cipher Mining Inc | William Iwaschuk | Co-President and CLO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 305,707 | 611,413 | - | - | Performance Stock Units | |
| Cipher Mining Inc | William Iwaschuk | Co-President and CLO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 305,707 | 1,585,565 | - | 0 | Common Stock | |
| MoonLake Immunotherapeutics (Class A) | Matthias Bodenstedt | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Dec 2025 | 294,473 | 0 | - | - | Class C ordinary shares, par value $0.0001 per share | |
| MoonLake Immunotherapeutics (Class A) | Matthias Bodenstedt | Chief Financial Officer | 19 Dec 2025 | 294,473 | 922,009 | - | - | Class A ordinary shares, par value $0.0001 per share | ||
| Skillz Inc (Class A) | Andrew Paradise | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 285,714 | 285,714 | - | - | Restricted Stock Units | |
| Flora Growth Corp | Dany Vaiman | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 235,604 | 235,604 | - | - | Employee Stock Option ("Right to Buy") | |
| Olema Pharma Inc | Ian T. Clark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.41 per share. | 19 Dec 2025 | 209,690 | 209,690 | - | 4.4 | 923,894 | Common Stock |
| Olema Pharma Inc | Ian T. Clark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 209,690 | 0 | - | - | Stock Option (Right to Buy) | |
| Amprius Tech Inc | Thomas M. Stepien | Director, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 200,000 | 610,000 | - | 0 | Common stock | |
| Immunome Inc | Clay B. Siegall | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Dec 2025 | 200,000 | 660,525 | - | 0 | Common Stock | |
| Replimune Grp Inc | Sushil Patel | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 200,000 | 533,576 (1%) | 0% | 0 | Common Stock | |
| Finance of America Companies Inc | Graham A. Fleming | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 200,000 | 200,000 | - | - | Stock Options (Right to Buy) | |
| Finance of America Companies Inc | Jeremy Prahm | Chief Investment Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 200,000 | 200,000 | - | - | Stock Options (Right to Buy) | |
| Intuitive Machines Inc (Class A) | Timothy Crain | SVP and Chief Growth Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 200,000 | 9,220,615 | - | - | Common Units | |
| Intuitive Machines Inc (Class A) | Timothy Crain | SVP and Chief Growth Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 16.04 per share. | 19 Dec 2025 | 200,000 | 298,435 | - | 16.0 | 3,207,280 | Class A Common Stock |
| Intuitive Machines Inc (Class A) | Timothy Crain | SVP and Chief Growth Officer, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Dec 2025 | 200,000 | 9,220,615 | - | - | Class C Common Stock | |
| Intuitive Machines Inc (Class A) | Timothy Crain | SVP and Chief Growth Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 200,000 | 498,435 | - | - | Class A Common Stock | |
| MoonLake Immunotherapeutics (Class A) | Jorge Santos da Silva | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Dec 2025 | 196,316 | 0 | - | - | Class C ordinary shares, par value $0.0001 per share | |
| MoonLake Immunotherapeutics (Class A) | Jorge Santos da Silva | Director, Chief Executive Officer | 19 Dec 2025 | 196,316 | 3,074,893 | - | - | Class A ordinary shares, par value $0.0001 per share | ||
| Olema Pharma Inc | Ian T. Clark | Director | Sale of securities on an exchange or to another person at price $ 29.71 per share. | 19 Dec 2025 | 193,056 | 41,840 | - | 29.7 | 5,735,694 | Common Stock |
| Cipher Mining Inc | William Iwaschuk | Co-President and CLO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.21 per share. | 19 Dec 2025 | 169,056 | 1,416,509 | - | 16.2 | 2,740,398 | Common Stock |
| Aflac Inc | Daniel P. Amos | Director, Chairman of the Board, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Dec 2025 | 161,175 | 580,840 (0%) | 0% | 0 | Common Stock | |
| QuantumScape Corp (Class A) | Jeffrey B. Straubel | Director | Sale of securities on an exchange or to another person at price $ 11.38 per share. | 19 Dec 2025 | 157,171 | 266,828 | - | 11.4 | 1,788,999 | Class A Common Stock |
| Cipher Mining Inc | Patrick Kelly | Co-President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.21 per share. | 19 Dec 2025 | 156,064 | 1,548,212 | - | 16.2 | 2,529,797 | Common Stock |
| Finance of America Companies Inc | Kristen N. Sieffert | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 150,000 | 150,000 | - | - | Stock Options (Right to Buy) | |
| Hycroft Mining Holding Corp (Class A) | Eric Steven Sprott | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 16.31 per share. | 19 Dec 2025 | 150,000 | 30,756,352 | - | 16.3 | 2,446,500 | Class A common stock |
| Healthequity Inc | Stephen D. Neeleman | Director, FOUNDER AND VICE CHAIRMAN | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Dec 2025 | 140,000 | 409,735 (0%) | 0% | 0 | Common Stock | |
| Healthequity Inc | Stephen D. Neeleman | Director, FOUNDER AND VICE CHAIRMAN | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Dec 2025 | 140,000 | 140,000 (0%) | 0% | 0 | Common Stock | |
| Xeris Biopharma Holdings Inc | John H. Johnson | Director | Sale of securities on an exchange or to another person at price $ 7.22 per share. | 19 Dec 2025 | 135,400 | 698,083 (2%) | 0% | 7.2 | 977,019 | Common Stock |
| Applied Materials | Gary E. Dickerson | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 256.41 per share. | 19 Dec 2025 | 130,843 | 1,778,116 (0%) | 0% | 256.4 | 33,549,454 | Common Stock |
| QuantumScape Corp (Class A) | Jeffrey B. Straubel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 130,065 | 0 | - | - | Stock Option (Right to Buy) | |
| QuantumScape Corp (Class A) | Jeffrey B. Straubel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.38 per share. | 19 Dec 2025 | 130,065 | 423,999 | - | 2.4 | 309,165 | Class A Common Stock |
| Asana Inc (Class A) | Justin Rosenstein | Director | Other type of transaction at price $ 0.00 per share. | 19 Dec 2025 | 125,000 | 722,458 | - | - | Class B Common Stock | |
| Asana Inc (Class A) | Justin Rosenstein | Director | Other type of transaction at price $ 0.00 per share. | 19 Dec 2025 | 125,000 | 7,176,532 | - | - | Class B Common Stock | |
| Celsius Holdings Inc | William H. Milmoe | Ten Percent Owner | 19 Dec 2025 | 120,000 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
| Celsius Holdings Inc | William H. Milmoe | Ten Percent Owner | 19 Dec 2025 | 120,000 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
| Celsius Holdings Inc | William H. Milmoe | Ten Percent Owner | 19 Dec 2025 | 120,000 | 14,362,396 (20%) | 0% | 38.8 | 4,654,932 | Common Stock | |
| Celsius Holdings Inc | William H. Milmoe | Ten Percent Owner | 19 Dec 2025 | 120,000 | 14,482,396 (21%) | 0% | 38.8 | 4,654,932 | Common Stock | |
| Celsius Holdings Inc | Dean Desantis | Ten Percent Owner | 19 Dec 2025 | 120,000 | 14,482,396 (21%) | 0% | 38.8 | 4,654,932 | Common Stock | |
| Celsius Holdings Inc | Dean Desantis | Ten Percent Owner | 19 Dec 2025 | 120,000 | 14,362,396 (20%) | 0% | 38.8 | 4,654,932 | Common Stock | |
| Celsius Holdings Inc | Dean Desantis | Ten Percent Owner | 19 Dec 2025 | 120,000 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
| Celsius Holdings Inc | Dean Desantis | Ten Percent Owner | 19 Dec 2025 | 120,000 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
| Celsius Holdings Inc | Deborah DeSantis | Ten Percent Owner | 19 Dec 2025 | 120,000 | 14,482,396 (21%) | 0% | 38.8 | 4,654,932 | Common Stock | |
| Celsius Holdings Inc | Deborah DeSantis | Ten Percent Owner | 19 Dec 2025 | 120,000 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
| Celsius Holdings Inc | Deborah DeSantis | Ten Percent Owner | 19 Dec 2025 | 120,000 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
| Celsius Holdings Inc | Deborah DeSantis | Ten Percent Owner | 19 Dec 2025 | 120,000 | 14,362,396 (20%) | 0% | 38.8 | 4,654,932 | Common Stock | |
| Intuitive Machines Inc (Class A) | Stephen Altemus | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 16.71 per share. | 19 Dec 2025 | 118,259 | 1,026,402 | - | 16.7 | 1,975,682 | Class A Common Stock |
| Celsius Holdings Inc | William H. Milmoe | Ten Percent Owner | 19 Dec 2025 | 115,374 | 14,602,396 (21%) | 0% | 38.8 | 4,475,484 | Common Stock | |
| Celsius Holdings Inc | William H. Milmoe | Ten Percent Owner | 19 Dec 2025 | 115,374 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
| Celsius Holdings Inc | Dean Desantis | Ten Percent Owner | 19 Dec 2025 | 115,374 | 14,602,396 (21%) | 0% | 38.8 | 4,475,484 | Common Stock | |
| Celsius Holdings Inc | Dean Desantis | Ten Percent Owner | 19 Dec 2025 | 115,374 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
| Celsius Holdings Inc | Deborah DeSantis | Ten Percent Owner | 19 Dec 2025 | 115,374 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
| Celsius Holdings Inc | Deborah DeSantis | Ten Percent Owner | 19 Dec 2025 | 115,374 | 14,602,396 (21%) | 0% | 38.8 | 4,475,484 | Common Stock | |
| Xencor Inc | Bassil I. Dahiyat | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.51 per share. | 19 Dec 2025 | 114,377 | 581,012 (1%) | 0% | 12.5 | 1,430,856 | Common Stock |
| Xencor Inc | Bassil I. Dahiyat | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 114,377 | 10,624 | - | - | Stock Option (Right to Buy) | |
| Xencor Inc | Bassil I. Dahiyat | Director, PRESIDENT & CEO | Sale of securities on an exchange or to another person at price $ 15.71 per share. | 19 Dec 2025 | 114,377 | 466,635 (0%) | 0% | 15.7 | 1,796,863 | Common Stock |
| Nexalin Tech Inc | Benjamin V. Hu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 100,000 | 100,000 | - | - | Stock Option (right to buy)* | |
| Nexalin Tech Inc | Alan Kazden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 100,000 | 362,500 | - | - | Stock Option (right to buy)* | |
| Nexalin Tech Inc | Carolyn Shelton | Sr. VP - Quality - Regulatory | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 100,000 | 210,620 | - | - | Stock Option (right to buy)* | |
| Nexalin Tech Inc | Justin Van Fleet | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 100,000 | 230,435 | - | - | Stock Option (right to buy)* | |
| Olema Pharma Inc | Naseem Zojwalla | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 28.04 per share. | 19 Dec 2025 | 100,000 | 53,997 | - | 28.0 | 2,804,000 | Common Stock |
| Olema Pharma Inc | Naseem Zojwalla | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 27.66 per share. | 19 Dec 2025 | 99,509 | 4,488 | - | 27.7 | 2,752,419 | Common Stock |
| Eventbrite Inc (Class A) | Ted Dworkin | Chief Product Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.43 per share. | 19 Dec 2025 | 98,988 | 775,595 (1%) | 0% | 4.4 | 438,517 | Class A Common Stock |
| Kroger | Ronald L. Sargent | Chairman and Interim CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 96,139 | 281,565 (0%) | 0% | 0 | Common Stock | |
| LiqTech Intl Inc | David Kowalczyk | CFO and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 94,368 | 94,368 (0%) | 0% | 0 | Common Stock | |
| Innovative Eyewear Inc | Vladimir Galkin | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.22 per share. | 19 Dec 2025 | 90,709 | 796,007 | - | 1.2 | 110,665 | Common Stock, par value $0.00001 |
| Cosmos Health Inc | Grigorios Siokas | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.49 per share. | 19 Dec 2025 | 88,314 | 6,716,771 | - | 0.5 | 43,000 | Common Stock, par value $.001 |
| Northpointe Bancshares Inc | David J. Christel | PRES, MORTGAGE PURCH PROGRAM | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 85,896 | 171,793 | - | - | Restricted stock units | |
| Northpointe Bancshares Inc | David J. Christel | PRES, MORTGAGE PURCH PROGRAM | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 85,896 | 235,896 | - | 0 | Common Stock | |
| Joby Aviation Inc | JoeBen Bevirt | Director, CEO and Chief Architect, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Dec 2025 | 83,666 | 0 | - | 0 | Common Stock | |
| Northpointe Bancshares Inc | Kevin J. Comps | PRESIDENT & SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 79,696 | 159,393 | - | - | Restricted stock units | |
| Northpointe Bancshares Inc | Kevin J. Comps | PRESIDENT & SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 79,696 | 80,696 | - | 0 | Common Stock | |
| Turning Point Brands Inc | David E. Glazek | Director, Executive Chairman | Other type of transaction at price $ 0.00 per share. | 19 Dec 2025 | 78,000 | 78,000 | - | - | Forward contract | |
| Eventbrite Inc (Class A) | Lisa Gorman | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.43 per share. | 19 Dec 2025 | 77,483 | 564,486 (0%) | 0% | 4.4 | 343,250 | Class A Common Stock |
| Skillz Inc (Class A) | Gaetano Franceschi | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 76,190 | 76,190 | - | - | Restricted Stock Unit | |
| Hecla Mining Co. | Michael L. Clary | Sr. VP & CAO | Sale of securities on an exchange or to another person at price $ 20.30 per share. | 19 Dec 2025 | 75,000 | 356,672 (0%) | 0% | 20.3 | 1,522,500 | Common Stock |
| Finance of America Companies Inc | Lauren Richmond | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 75,000 | 75,000 | - | - | Stock Options (Right to Buy) | |
| Xencor Inc | John R. Desjarlais | SR. VICE PRESIDENT & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.51 per share. | 19 Dec 2025 | 73,367 | 309,941 (0%) | 0% | 12.5 | 917,821 | Common Stock |
| Xencor Inc | John R. Desjarlais | SR. VICE PRESIDENT & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 73,367 | 11,633 | - | - | Stock Option (Right to Buy) | |
| Xencor Inc | John R. Desjarlais | SR. VICE PRESIDENT & CSO | Sale of securities on an exchange or to another person at price $ 15.72 per share. | 19 Dec 2025 | 73,367 | 236,574 (0%) | 0% | 15.7 | 1,153,329 | Common Stock |
| Wealthfront Corp | David Fortunato | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.39 per share. | 19 Dec 2025 | 71,942 | 1,658,900 | - | 1.4 | 99,999 | Common Stock |
| Wealthfront Corp | David Fortunato | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 71,942 | 2,828,058 | - | - | Stock Option (Right to Buy) | |
| Skillz Inc (Class A) | Andrew Paradise | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 71,430 | 1,077,422 | - | 0 | Class A common stock | |
| Skillz Inc (Class A) | Andrew Paradise | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 71,430 | 214,284 | - | - | Restricted Stock Units | |
| MEI Pharma Inc | James Flynn | Director | Purchase of securities on an exchange or from another person at price $ 1.40 per share. | 19 Dec 2025 | 70,000 | 100,000 (0%) | 0% | 1.4 | 97,699 | Common Stock |
| Celularity Inc (Class A) | Peter H. Diamandis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 67,416 | 248,765 | - | 0 | Class A Common Stock | |
| Celularity Inc (Class A) | Diane L. Parks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 67,416 | 365,021 | - | 0 | Class A Common Stock | |
| Celularity Inc (Class A) | Geoffrey Shiu Fei Ling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 67,416 | 111,795 | - | 0 | Class A Common Stock | |
| Skillz Inc (Class A) | Gaetano Franceschi | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 65,359 | 0 | - | - | Restricted Stock Unit | |
| Skillz Inc (Class A) | Gaetano Franceschi | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 65,359 | 122,501 | - | 0 | Class A common stock | |
| Stanley Black & Decker | Agustin Lopez Diaz | SVP Chief Supply Chain Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 61,868 | 61,868 | - | - | Restricted Stock Units | |
| Biocryst Pharma Inc | Jon P. Stonehouse | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.41 per share. | 19 Dec 2025 | 61,793 | 1,323,429 (0%) | 0% | 7.4 | 457,886 | Common Stock |
| Replimune Grp Inc | Emily Hill | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 60,000 | 194,368 (0%) | 0% | 0 | Common Stock | |
| Replimune Grp Inc | Konstantinos Xynos | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 60,000 | 199,685 (0%) | 0% | 0 | Common Stock | |
| Tutor Perini Corp | Ronald N. Tutor | Director, Ten Percent Owner, Executive Chairman | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Dec 2025 | 60,000 | 711,477 (1%) | 0% | 0 | Common Stock | |
| Elanco Animal Health Inc | R. David Hoover | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Dec 2025 | 60,000 | 150,000 (0%) | 0% | 0 | Common Stock | |
| LifeStance Health Grp Inc | Robert Bessler | Director | Sale of securities on an exchange or to another person at price $ 7.04 per share. | 19 Dec 2025 | 59,971 | 1,318,983 | - | 7.0 | 422,196 | Common Stock |
| LifeStance Health Grp Inc | Robert Bessler | Director | Sale of securities on an exchange or to another person at price $ 7.04 per share. | 19 Dec 2025 | 59,971 | 1,435,783 | - | 7.0 | 422,196 | Common Stock |
| Rexford Industrial Realty Inc | Laura Clark | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 59,873 | 148,420 | - | - | LTIP Units | |
| Intuitive Machines Inc (Class A) | Timothy Crain | SVP and Chief Growth Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 19 Dec 2025 | 58,800 | 298,435 | - | 15.0 | 881,741 | Class A Common Stock |
| Intuitive Machines Inc (Class A) | Timothy Crain | SVP and Chief Growth Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 14.19 per share. | 19 Dec 2025 | 57,473 | 357,235 | - | 14.2 | 815,392 | Class A Common Stock |
| Skillz Inc (Class A) | Gaetano Franceschi | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 57,144 | 19,046 | - | - | Restricted Stock Unit | |
| Skillz Inc (Class A) | Gaetano Franceschi | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 57,142 | 57,142 | - | 0 | Class A common stock | |
| Olema Pharma Inc | Naseem Zojwalla | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 28.03 per share. | 19 Dec 2025 | 57,079 | 116,918 | - | 28.0 | 1,599,924 | Common Stock |
| Nuvalent Inc (Class A) | James R. Porter | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.65 per share. | 19 Dec 2025 | 57,000 | 306,062 | - | 0.7 | 37,050 | Class A Common Stock |
| Nuvalent Inc (Class A) | James R. Porter | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 57,000 | 508,942 | - | - | Stock Option (Right to Buy) | |
| Wealthfront Corp | David Fortunato | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 55,865 | 576,135 | - | - | Stock Option (Right to Buy) | |
| Wealthfront Corp | David Fortunato | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.79 per share. | 19 Dec 2025 | 55,865 | 1,768,240 | - | 1.8 | 99,998 | Common Stock |
| Unitedhealth Grp | Stephen J. Hemsley | Director, CEO, UHG | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Dec 2025 | 55,000 | 372,947 (0%) | 0% | 0 | Common Stock | |
| Spar Grp Inc | Steven Michael Hennen | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.78 per share. | 19 Dec 2025 | 55,000 | 55,000 (0%) | 0% | 0.8 | 42,900 | Common Stock, $.01 par value |
| Wealthfront Corp | David Fortunato | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.87 per share. | 19 Dec 2025 | 53,475 | 1,712,375 | - | 1.9 | 99,998 | Common Stock |
| Wealthfront Corp | David Fortunato | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 53,475 | 1,333,555 | - | - | Stock Option (Right to Buy) | |
| Allstate | Thomas J. Wilson | Director, Chairman, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Dec 2025 | 50,134 | 324,088 (0%) | 0% | 0 | Common Stock | |
| Allstate | Thomas J. Wilson | Director, Chairman, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Dec 2025 | 50,134 | 0 (0%) | 0% | 0 | Common Stock | |
| Helmerich & Payne Inc | Hans Helmerich | Director | Sale of securities on an exchange or to another person at price $ 28.13 per share. | 19 Dec 2025 | 50,000 | 1,215,915 (1%) | 0% | 28.1 | 1,406,500 | Common Stock |
| Jabil | Mark T. Mondello | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 225.32 per share. | 19 Dec 2025 | 50,000 | 1,171,459 (0%) | 0% | 225.3 | 11,266,000 | Common Stock |
| Biocryst Pharma Inc | Charles K. Gayer | President and CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 50,000 | 0 | - | - | Emp. Stock Option (Right to Buy) | |
| Biocryst Pharma Inc | Charles K. Gayer | President and CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.51 per share. | 19 Dec 2025 | 50,000 | 952,583 (0%) | 0% | 5.5 | 275,500 | Common Stock |
| Mirum Pharma Inc | Michael G. Grey | Director | Sale of securities on an exchange or to another person at price $ 78.00 per share. | 19 Dec 2025 | 50,000 | 0 (0%) | 0% | 78 | 3,900,000 | Common Stock |
| Mirum Pharma Inc | Michael G. Grey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.94 per share. | 19 Dec 2025 | 50,000 | 50,000 (0%) | 0% | 2.9 | 146,800 | Common Stock |
| Mirum Pharma Inc | Michael G. Grey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 50,000 | 181,176 | - | - | Stock Option (right to buy) | |
| Olema Pharma Inc | Naseem Zojwalla | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 50,000 | 156,818 | - | - | Stock Option (Right to Buy) | |
| Olema Pharma Inc | Naseem Zojwalla | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.02 per share. | 19 Dec 2025 | 50,000 | 103,997 | - | 7.0 | 351,000 | Common Stock |
| Cipher Mining Inc | Wesley Williams | Director | Sale of securities on an exchange or to another person at price $ 16.08 per share. | 19 Dec 2025 | 49,867 | 158,145 | - | 16.1 | 801,861 | Common Stock |
| Origin Materials Inc | John Bissell | Director, CEO and Director | Sale of securities on an exchange or to another person at price $ 0.27 per share. | 19 Dec 2025 | 45,000 | 1,997,973 | - | 0.3 | 12,078 | Common Stock |
| UiPath Inc (Class A) | Daniel Dines | Director, CEO and Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 16.07 per share. | 19 Dec 2025 | 45,000 | 28,793,585 | - | 16.1 | 723,290 | Class A Commmon Stock |
| Finance of America Companies Inc | Matthew A. Engel | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 45,000 | 45,000 | - | - | Stock Options (Right to Buy) | |
| Olema Pharma Inc | David C. Myles | CH. DISCOV. & NON-CLIN DEV OFF | Sale of securities on an exchange or to another person at price $ 30.40 per share. | 19 Dec 2025 | 43,729 | 557,927 | - | 30.4 | 1,329,362 | Common Stock |
| Intuitive Machines Inc (Class A) | Timothy Crain | SVP and Chief Growth Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 42,944 | 448,435 | - | - | Class A Common Stock | |
| Intuitive Machines Inc (Class A) | Timothy Crain | SVP and Chief Growth Officer, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Dec 2025 | 42,944 | 9,420,615 | - | - | Class C Common Stock | |
| Intuitive Machines Inc (Class A) | Timothy Crain | SVP and Chief Growth Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 42,944 | 9,420,615 | - | - | Common Units | |
| Olema Pharma Inc | Naseem Zojwalla | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.25 per share. | 19 Dec 2025 | 42,818 | 146,815 | - | 15.3 | 652,975 | Common Stock |
| Olema Pharma Inc | Naseem Zojwalla | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 42,818 | 112,182 | - | - | Stock Option (Right to Buy) | |
| Olema Pharma Inc | Ian T. Clark | Director | Sale of securities on an exchange or to another person at price $ 30.48 per share. | 19 Dec 2025 | 41,840 | 0 | - | 30.5 | 1,275,283 | Common Stock |
| Intuitive Machines Inc (Class A) | Stephen Altemus | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 41,407 | 1,067,809 | - | - | Class A Common Stock | |
| Intuitive Machines Inc (Class A) | Stephen Altemus | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 41,407 | 15,300,806 | - | - | Common Units | |
| Intuitive Machines Inc (Class A) | Stephen Altemus | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 15.01 per share. | 19 Dec 2025 | 41,407 | 1,026,402 | - | 15.0 | 621,697 | Class A Common Stock |
| Intuitive Machines Inc (Class A) | Stephen Altemus | Director, Chief Executive Officer, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Dec 2025 | 41,407 | 15,300,806 | - | - | Class C Common Stock | |
| Recursion Pharma Inc (Class A) | Christopher Gibson | Director, Chief Executive Officer | 19 Dec 2025 | 40,000 | 953,839 | - | 0 | Class A Common Stock | ||
| Recursion Pharma Inc (Class A) | Christopher Gibson | Director, Chief Executive Officer | 19 Dec 2025 | 40,000 | 4,723,334 | - | - | Class B Common Stock | ||
| Recursion Pharma Inc (Class A) | Christopher Gibson | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 4.50 per share. | 19 Dec 2025 | 40,000 | 913,839 | - | 4.5 | 180,000 | Class A Common Stock |
| Olema Pharma Inc | Naseem Zojwalla | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.25 per share. | 19 Dec 2025 | 40,000 | 173,997 | - | 15.3 | 610,000 | Common Stock |
| Olema Pharma Inc | Naseem Zojwalla | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 40,000 | 155,000 | - | - | Stock Option (Right to Buy) | |
| Reddit Inc (Class A) | Jennifer L. Wong | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.35 per share. | 19 Dec 2025 | 39,167 | 1,223,695 | - | 5.3 | 209,543 | Class A Common Stock |
| Reddit Inc (Class A) | Jennifer L. Wong | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 39,167 | 266,627 | - | - | Stock Option (Right to Buy) | |
| PotlatchDeltic Corp | Eric J. Cremers | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 37,446 | 320,166 (0%) | 0% | 0 | Common Stock | |
| MoonLake Immunotherapeutics (Class A) | Kristian Reich | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Dec 2025 | 35,389 | 0 | - | - | Class C ordinary shares, par value $0.0001 per share | |
| MoonLake Immunotherapeutics (Class A) | Kristian Reich | Chief Scientific Officer | 19 Dec 2025 | 35,389 | 35,389 | - | - | Class A ordinary shares, par value $0.0001 per share | ||
| InMed Pharma Inc | Eric A. Adams | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 35,000 | 49,050 | - | - | Employee Stock Option (Right to Buy) | |
| Replimune Grp Inc | Christopher Sarchi | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 35,000 | 158,088 (0%) | 0% | 0 | Common Stock | |
| Northpointe Bancshares Inc | Kevin J. Comps | PRESIDENT & SECRETARY | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.67 per share. | 19 Dec 2025 | 34,744 | 45,952 | - | 17.7 | 613,938 | Common Stock |
| Northpointe Bancshares Inc | David J. Christel | PRES, MORTGAGE PURCH PROGRAM | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.67 per share. | 19 Dec 2025 | 33,800 | 202,096 | - | 17.7 | 597,258 | Common Stock |
| Applied Materials | Prabu G. Raja | President, Semi. Products Grp. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 256.41 per share. | 19 Dec 2025 | 33,406 | 169,328 (0%) | 0% | 256.4 | 8,565,632 | Common Stock |
| Innovative Eyewear Inc | Vladimir Galkin | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.33 per share. | 19 Dec 2025 | 32,958 | 887,644 | - | 1.3 | 43,834 | Common Stock, par value $0.00001 |
| Fossil Grp Inc | Kevin Mansell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 30,577 | 125,536 (0%) | 0% | 0 | Common Stock | |
| Fossil Grp Inc | Wendy L. Schoppert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 30,577 | 74,365 (0%) | 0% | 0 | Common Stock | |
| Fossil Grp Inc | Gail B. Tifford | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 30,577 | 166,502 (0%) | 0% | 0 | Common Stock | |
| Fossil Grp Inc | Pamela Beth Corrie | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 30,577 | 61,506 (0%) | 0% | 0 | Common Stock | |
| Fossil Grp Inc | Suzanne M. Coulter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 30,577 | 129,034 (0%) | 0% | 0 | Common Stock | |
| Fossil Grp Inc | Marc R. Y. Rey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 30,577 | 116,353 (0%) | 0% | 0 | Common Stock | |
| Fossil Grp Inc | Pamela J. Edwards | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 30,577 | 43,043 (0%) | 0% | 0 | Common Stock | |
| Turning Point Brands Inc | David E. Glazek | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.71 per share. | 19 Dec 2025 | 30,000 | 157,083 (0%) | 0% | 20.7 | 621,300 | Common Stock |
| Turning Point Brands Inc | David E. Glazek | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 110.26 per share. | 19 Dec 2025 | 30,000 | 127,083 (0%) | 0% | 110.3 | 3,307,800 | Common Stock |
| Turning Point Brands Inc | David E. Glazek | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 30,000 | 47,519 | - | - | Options | |
| OneStream Inc (Class A) | John Kinzer | Director, Strategic Advisor | 19 Dec 2025 | 30,000 | 30,000 | - | - | Class A Common Stock | ||
| OneStream Inc (Class A) | John Kinzer | Director, Strategic Advisor | 19 Dec 2025 | 30,000 | 0 | - | - | Class D Common Stock | ||
| OneStream Inc (Class A) | John Kinzer | Director, Strategic Advisor | 19 Dec 2025 | 30,000 | 30,000 | - | - | Class D Common Stock | ||
| OneStream Inc (Class A) | John Kinzer | Director, Strategic Advisor | 19 Dec 2025 | 30,000 | 270,997 | - | - | Common Units | ||
| Olema Pharma Inc | Ian T. Clark | Director | Sale of securities on an exchange or to another person at price $ 28.83 per share. | 19 Dec 2025 | 29,904 | 234,896 | - | 28.8 | 862,132 | Common Stock |
| Applied Materials | Brice A. Hill | SVP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 256.41 per share. | 19 Dec 2025 | 28,062 | 143,565 (0%) | 0% | 256.4 | 7,195,377 | Common Stock |
| Globe Life | Frank M. Svoboda | Director, Co-Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Dec 2025 | 26,425 | 108,473 (0%) | 0% | 0 | Common Stock | |
| Globe Life | Frank M. Svoboda | Director, Co-Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Dec 2025 | 26,425 | 26,425 (0%) | 0% | 0 | Common Stock | |
| Cipher Mining Inc | William Iwaschuk | Co-President and CLO | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Dec 2025 | 26,000 | 1,390,509 | - | 0 | Common Stock | |
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Sale of securities on an exchange or to another person at price $ 14.17 per share. | 19 Dec 2025 | 25,642 | 245,690 (0%) | 0% | 14.2 | 363,380 | Common Stock |
| Helmerich & Payne Inc | Hans Helmerich | Director | Sale of securities on an exchange or to another person at price $ 28.10 per share. | 19 Dec 2025 | 25,000 | 496,735 (0%) | 0% | 28.1 | 702,500 | Common Stock |
| Intuitive Machines Inc (Class A) | Timothy Crain | SVP and Chief Growth Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 13.20 per share. | 19 Dec 2025 | 24,986 | 414,708 | - | 13.2 | 329,840 | Class A Common Stock |
| USA Compression Partners LP - Unit | Christopher W Porter | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 24,458 | 16,304 | - | - | Phantom Units | |
| USA Compression Partners LP - Unit | Christopher W Porter | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 24,458 | 160,230 (0%) | 0% | - | Common Units | |
| PotlatchDeltic Corp | Eric J. Cremers | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 39.33 per share. | 19 Dec 2025 | 24,123 | 296,043 (0%) | 0% | 39.3 | 948,758 | Common Stock |
| Northpointe Bancshares Inc | Amy M. Butler | EVP, NATIONAL SALES | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 23,096 | 23,096 | - | 0 | Common Stock | |
| Northpointe Bancshares Inc | Amy M. Butler | EVP, NATIONAL SALES | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 23,096 | 46,193 | - | - | Restricted stock units | |
| Matthews Intl Corp (Class A) | Lee Lane | EVP (Group Pres Ind and Envir) | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 22,470 | 22,470 | - | - | Restricted Share Units | |
| Vestis Corp | Adam K. Bowen | Interim CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 21,835 | 85,789 | - | 0 | Common Stock, par value $0.01 per share | |
| Cipher Mining Inc | James E. Newsome | Director | Sale of securities on an exchange or to another person at price $ 16.03 per share. | 19 Dec 2025 | 21,821 | 172,492 | - | 16.0 | 349,791 | Common Stock |
| Biocryst Pharma Inc | Alane P. Barnes | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 7.65 per share. | 19 Dec 2025 | 21,773 | 398,751 (0%) | 0% | 7.6 | 166,563 | Common Stock |
| Olema Pharma Inc | Ian T. Clark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 21,520 | 0 | - | - | Stock Option (Right to Buy) | |
| Olema Pharma Inc | Ian T. Clark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 21,520 | 0 | - | - | Stock Option (Right to Buy) | |
| Olema Pharma Inc | Ian T. Clark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.84 per share. | 19 Dec 2025 | 21,520 | 252,730 | - | 7.8 | 168,717 | Common Stock |
| Olema Pharma Inc | Ian T. Clark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.61 per share. | 19 Dec 2025 | 21,520 | 231,210 | - | 3.6 | 77,687 | Common Stock |
| Applied Materials | Omkaram Nalamasu | Senior Vice President, CTO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 256.41 per share. | 19 Dec 2025 | 20,307 | 181,868 (0%) | 0% | 256.4 | 5,206,918 | Common Stock |
| Savara Inc | David A. Ramsay | Director | Sale of securities on an exchange or to another person at price $ 6.06 per share. | 19 Dec 2025 | 20,000 | 2,533,642 (4%) | 0% | 6.1 | 121,220 | Common Stock |
| Universal Insurance Holdings Inc | Sean P. Downes | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 33.82 per share. | 19 Dec 2025 | 20,000 | 1,243,512 (3%) | 0% | 33.8 | 676,316 | Common Stock |
| VICI Properties | Edward Baltazar Pitoniak | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Dec 2025 | 20,000 | 1,243,683 (0%) | 0% | 0 | Common Stock | |
| Royalty Pharma PLC (Class A) | Marshall Urist | EVP, Research & Investments | Sale of securities on an exchange or to another person at price $ 38.38 per share. | 19 Dec 2025 | 20,000 | 120,000 | - | 38.4 | 767,582 | Class A Ordinary Shares |
| Finance of America Companies Inc | Tai A. Thornock | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 20,000 | 20,000 | - | - | Stock Options (Right to Buy) | |
| Jack In The Box Inc | Alan Smolinisky | Director | 19 Dec 2025 | 20,000 | 160,646 (0%) | 0% | 22.5 | 450,000 | Common Stock | |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 66.49 per share. | 19 Dec 2025 | 19,805 | 90,178 (0%) | 0% | 66.5 | 1,316,834 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 19,805 | 0 | - | - | Stock Option (Right to Buy) | |
| Rexford Industrial Realty Inc | Michael P. Fitzmaurice | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 19,431 | 19,431 | - | - | LTIP Units | |
| Epsilon Energy Ltd | Jason Stabell | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 4.59 per share. | 19 Dec 2025 | 19,100 | 535,039 (1%) | 0% | 4.6 | 87,669 | Common Shares |
| APA | Stephen J. Riney | President | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Dec 2025 | 18,888 | 1 (0%) | 0% | 0 | Common Stock | |
| APA | Stephen J. Riney | President | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Dec 2025 | 18,888 | 194,589 (0%) | 0% | 0 | Common Stock | |
| BigBear.ai Holdings Inc | Paul E. Fulchino | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 18,650 | 404,760 | - | 0 | Common Stock | |
| USA Compression Partners LP - Unit | Christopher W Porter | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 18,568 | 145,056 (0%) | 0% | - | Common Units | |
| USA Compression Partners LP - Unit | Christopher W Porter | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 18,568 | 0 | - | - | Phantom Units | |
| Red Violet Inc | Derek Dubner | Director, Chief Executive Officer, Chairman of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 18,520 | 569,273 (4%) | 0% | - | Common Stock | |
| Red Violet Inc | Daniel MacLachlan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 18,520 | 370,436 (3%) | 0% | - | Common Stock | |
| Red Violet Inc | James P. Reilly | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 18,520 | 244,351 (2%) | 0% | - | Common Stock | |
| Reddit Inc (Class A) | Jennifer L. Wong | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 233.34 per share. | 19 Dec 2025 | 18,359 | 1,202,294 | - | 233.3 | 4,283,889 | Class A Common Stock |
| Vertiv Holdings Co (Class A) | Roger B. Fradin | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Dec 2025 | 18,313 | 0 (0%) | 0% | 0 | Class A Common Stock | |
| Vertiv Holdings Co (Class A) | Roger B. Fradin | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Dec 2025 | 18,313 | 18,313 (0%) | 0% | 0 | Class A Common Stock | |
| Vertiv Holdings Co (Class A) | Roger B. Fradin | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Dec 2025 | 18,313 | 0 (0%) | 0% | 0 | Class A Common Stock | |
| Vertiv Holdings Co (Class A) | Roger B. Fradin | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Dec 2025 | 18,313 | 18,313 (0%) | 0% | 0 | Class A Common Stock | |
| InMed Pharma Inc | Michael Woudenberg | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 18,000 | 25,445 | - | - | Employee Stock Option (Right to Buy) | |
| InMed Pharma Inc | N. Netta Jagpal | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 18,000 | 24,250 | - | - | Employee Stock Option (Right to Buy) | |
| Phreesia Inc | Amy Beth VanDuyn | SVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.71 per share. | 19 Dec 2025 | 18,000 | 162,840 (0%) | 0% | 4.7 | 84,780 | Common Stock |
| Phreesia Inc | Amy Beth VanDuyn | SVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 18,000 | 4,755 | - | - | Stock Option (Right to Buy) | |
| NCR Atleos Corp | Timothy C. Oliver | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.92 per share. | 19 Dec 2025 | 17,084 | 321,267 | - | 38.9 | 664,909 | Common Stock |
| Biocryst Pharma Inc | Alane P. Barnes | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.41 per share. | 19 Dec 2025 | 16,902 | 420,524 (0%) | 0% | 7.4 | 125,244 | Common Stock |
| Intapp Inc | Thad Jampol | Chief Product Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 16,787 | 16,788 | - | - | Employee Stock Option (Right to Buy) | |
| Intapp Inc | Thad Jampol | Chief Product Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.45 per share. | 19 Dec 2025 | 16,787 | 902,334 | - | 7.4 | 125,063 | Common Stock |
| Applied Materials | Timothy M. Deane | SVP, Applied Global Services | Payment of exercise price or tax liability using portion of securities received from the company at price $ 256.41 per share. | 19 Dec 2025 | 16,465 | 145,095 (0%) | 0% | 256.4 | 4,221,791 | Common Stock |
| Hecla Mining Co. | Michael L. Clary | Sr. VP & CAO | Other type of transaction at price $ 0.00 per share. | 19 Dec 2025 | 16,207 | 16,207 (0%) | 0% | 0 | Common Stock | |
| Arthur J. Gallagher | Walter D. Bay | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 79.59 per share. | 19 Dec 2025 | 15,850 | 95,399 (0%) | 0% | 79.6 | 1,261,502 | Common Stock |
| Arthur J. Gallagher | Walter D. Bay | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 15,850 | 0 | - | - | Non-qualified Stock Option | |
| Arthur J. Gallagher | Walter D. Bay | General Counsel | Sale of securities on an exchange or to another person at price $ 255.00 per share. | 19 Dec 2025 | 15,850 | 79,549 (0%) | 0% | 255 | 4,041,750 | Common Stock |
| Applied Materials | Teri A. Little | SVP, CLO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 256.41 per share. | 19 Dec 2025 | 15,472 | 91,949 (0%) | 0% | 256.4 | 3,967,176 | Common Stock |
| Supernus Pharma Inc | Frank Mottola | SVP, Chief Tech. Ops. Officer | Sale of securities on an exchange or to another person at price $ 50.47 per share. | 19 Dec 2025 | 15,000 | 15,496 (0%) | 0% | 50.5 | 757,050 | Common Stock |
| Supernus Pharma Inc | Frank Mottola | SVP, Chief Tech. Ops. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 15,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Supernus Pharma Inc | Frank Mottola | SVP, Chief Tech. Ops. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.30 per share. | 19 Dec 2025 | 15,000 | 30,496 (0%) | 0% | 25.3 | 379,500 | Common Stock |
| NCR Atleos Corp | Timothy C. Oliver | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.92 per share. | 19 Dec 2025 | 14,934 | 306,333 | - | 38.9 | 581,231 | Common Stock |
| Rexford Industrial Realty Inc | David E. Lanzer | General Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 14,913 | 65,245 | - | - | LTIP Units | |
| NVIDIA | Donald F. Robertson | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 180.45 per share. | 19 Dec 2025 | 14,300 | 428,550 (0%) | 0% | 180.4 | 2,580,365 | Common Stock |
| Biocryst Pharma Inc | Charles K. Gayer | President and CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.22 per share. | 19 Dec 2025 | 14,142 | 892,492 (0%) | 0% | 3.2 | 45,537 | Common Stock |
| Biocryst Pharma Inc | Charles K. Gayer | President and CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 14,142 | 0 | - | - | Emp. Stock Option (Right to Buy) | |
| Jabil | Frederic E. McCoy | EVP, Global Operations | Sale of securities on an exchange or to another person at price $ 225.15 per share. | 19 Dec 2025 | 14,104 | 100,376 (0%) | 0% | 225.2 | 3,175,516 | Common Stock |
| Red Violet Inc | Jeffrey Alan Dell | Chief Information Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 13,890 | 165,889 (1%) | 0% | - | Common Stock | |
| Capri Holdings Ltd | John D. Idol | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 13,164 | 2,215,809 (1%) | 0% | 0 | Ordinary shares, no par value | |
| Capri Holdings Ltd | John D. Idol | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 13,164 | 274,192 | - | - | Restricted share units | |
| Capri Holdings Ltd | John D. Idol | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.25 per share. | 19 Dec 2025 | 13,164 | 2,202,645 (1%) | 0% | 25.3 | 332,391 | Ordinary shares, no par value |
| USA Compression Partners LP - Unit | Christopher J. Wauson | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 13,065 | 8,709 | - | - | Phantom Units | |
| USA Compression Partners LP - Unit | Christopher J. Wauson | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 13,065 | 96,244 (0%) | 0% | - | Common Units | |
| Lightpath Tech Inc (Class A) | Shmuel Rubin | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Dec 2025 | 13,020 | 231,653 (0%) | 0% | 0 | Class A common stock | |
| InMed Pharma Inc | Eric C. Hsu | Sr. VP, Pre-Clinical Res/Dev | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 13,000 | 18,280 | - | - | Employee Stock Option (Right to Buy) | |
| Olema Pharma Inc | Naseem Zojwalla | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 28.93 per share. | 19 Dec 2025 | 12,921 | 103,997 | - | 28.9 | 373,805 | Common Stock |
| Skillz Inc (Class A) | Todd A. Valli | CHIEF ACCOUNTING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 12,610 | 12,610 | - | - | Restricted Stock Unit | |
| Everest Group | William F. Galtney | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Dec 2025 | 12,578 | 21,180 (0%) | 0% | 0 | Common Shares | |
| Rocket Lab USA Inc | Nina M. Armagno | Director | Sale of securities on an exchange or to another person at price $ 70.18 per share. | 19 Dec 2025 | 12,446 | 108,940 | - | 70.2 | 873,425 | Common Stock |
| Disc Medicine Inc | John D. Quisel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.01 per share. | 19 Dec 2025 | 12,300 | 184,128 | - | 1.0 | 12,423 | Common Stock |
| Disc Medicine Inc | John D. Quisel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 12,300 | 186,120 | - | - | Stock Option (Right to Buy) | |
| USA Compression Partners LP - Unit | Christopher W Porter | See Remarks | Sale or transfer of securities back to the company at price $ 24.27 per share. | 19 Dec 2025 | 12,229 | 148,001 (0%) | 0% | 24.3 | 296,798 | Common Units |
| Arrive AI Inc | Lora Taylor O'Toole | VP Business Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 12,082 | 12,082 | - | - | Restricted Stock Award | |
| Olema Pharma Inc | Ian T. Clark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 12,070 | 12,080 | - | - | Stock Option (Right to Buy) | |
| Olema Pharma Inc | Ian T. Clark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.08 per share. | 19 Dec 2025 | 12,070 | 264,800 | - | 4.1 | 49,246 | Common Stock |
| Biocryst Pharma Inc | Charles K. Gayer | President and CCO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.41 per share. | 19 Dec 2025 | 11,477 | 878,350 (0%) | 0% | 7.4 | 85,045 | Common Stock |
| FTI Consulting Inc | Curtis P. Lu | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 11,328 | 44,582 (0%) | 0% | 0 | Common Stock | |
| USA Rare Earth Inc (Class A) | David Kronenfeld | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 11,095 | 11,095 | - | - | Restricted Stock Units | |
| Murphy Oil Corp | R. Madison Murphy | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Dec 2025 | 10,800 | 1,484,881 (0%) | 0% | 0 | Common Stock | |
| Xencor Inc | Bassil I. Dahiyat | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 10,624 | 0 | - | - | Stock Option (Right to Buy) | |
| Xencor Inc | Bassil I. Dahiyat | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.51 per share. | 19 Dec 2025 | 10,624 | 477,259 (0%) | 0% | 12.5 | 132,906 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 77.55 per share. | 19 Dec 2025 | 10,548 | 73,593 (0%) | 0% | 77.5 | 817,997 | Common Stock |
| Designer Brands Inc (Class A) | Douglas M. Howe | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 10,546 | 115,418 | - | - | Dividend Equivalent Rights | |
| Urban Outfitters Inc | Richard A. Hayne | Director, CEO & Chairman of the Board, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 80.36 per share. | 19 Dec 2025 | 10,293 | 17,825,640 (18%) | 0% | 80.4 | 827,145 | Common Shares |
| Biocryst Pharma Inc | Charles K. Gayer | President and CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.04 per share. | 19 Dec 2025 | 10,091 | 902,583 (0%) | 0% | 5.0 | 50,859 | Common Stock |
| Biocryst Pharma Inc | Charles K. Gayer | President and CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 10,091 | 17,409 | - | - | Emp. Stock Option (Right to Buy) | |
| Arrowhead Pharma Inc | Christopher Anzalone | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 68.33 per share. | 19 Dec 2025 | 10,012 | 3,808,500 (3%) | 0% | 68.3 | 684,120 | Common Stock |
| Immunome Inc | Philip Tsai | Chief Technical Officer | Purchase of securities on an exchange or from another person at price $ 20.49 per share. | 19 Dec 2025 | 10,000 | 43,300 | - | 20.5 | 204,900 | Common Stock |
| Replimune Grp Inc | Andrew Schwendenman | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 10,000 | 78,284 (0%) | 0% | 0 | Common Stock | |
| Tyra Biosciences Inc | Robert J. More | Director | Sale of securities on an exchange or to another person at price $ 25.00 per share. | 19 Dec 2025 | 10,000 | 3,823,425 | - | 25 | 250,000 | Common Stock |
| Vicor Corp | Patrizio Vinciarelli | Director, Chairman and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 103.30 per share. | 19 Dec 2025 | 10,000 | 9,810,263 (34%) | 0% | 103.3 | 1,033,001 | Common Stock |
| Forward Ind Inc | Ryan David Navi | Chief Investment Officer | Purchase of securities on an exchange or from another person at price $ 7.08 per share. | 19 Dec 2025 | 10,000 | 10,000 (0%) | 0% | 7.1 | 70,800 | Common Stock |
| Oracle | Clayton M. Magouyrk | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 192.52 per share. | 19 Dec 2025 | 10,000 | 144,030 (0%) | 0% | 192.5 | 1,925,152 | Common Stock |
| Live Oak Bancshares Inc | James S. Mahan | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 36.17 per share. | 19 Dec 2025 | 10,000 | 3,067,844 (8%) | 0% | 36.2 | 361,734 | Voting Common Stock |
| Dollar General | Bryan D. Wheeler | EVP & Chief Merchandising Ofc | Sale of securities on an exchange or to another person at price $ 135.32 per share. | 19 Dec 2025 | 9,776 | 22,295 (0%) | 0% | 135.3 | 1,322,890 | Common Stock |
| Epsilon Energy Ltd | Jason Stabell | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 4.62 per share. | 19 Dec 2025 | 9,400 | 515,939 (1%) | 0% | 4.6 | 43,428 | Common Shares |
| USA Compression Partners LP - Unit | Christopher W Porter | See Remarks | Sale or transfer of securities back to the company at price $ 24.27 per share. | 19 Dec 2025 | 9,284 | 135,772 (0%) | 0% | 24.3 | 225,323 | Common Units |
| Zumiez Inc | Travis D. Smith | Director | Sale of securities on an exchange or to another person at price $ 28.36 per share. | 19 Dec 2025 | 9,175 | 22,954 (0%) | 0% | 28.4 | 260,228 | Common Stock |
| Urban Outfitters Inc | Margaret A. Hayne | Director, Co-President & CCO | Sale of securities on an exchange or to another person at price $ 80.36 per share. | 19 Dec 2025 | 9,007 | 2,263,054 (2%) | 0% | 80.4 | 723,803 | Common Shares |
| Urban Outfitters Inc | Richard A. Hayne | Director, CEO & Chairman of the Board, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 80.36 per share. | 19 Dec 2025 | 9,007 | 2,263,054 (2%) | 0% | 80.4 | 723,803 | Common Shares |
| Olema Pharma Inc | David C. Myles | CH. DISCOV. & NON-CLIN DEV OFF | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Dec 2025 | 9,000 | 542,881 | - | 0 | Common Stock | |
| MoonLake Immunotherapeutics (Class A) | Matthias Bodenstedt | Chief Financial Officer | 19 Dec 2025 | 8,754 | 0 | - | - | Common shares, par value CHF 0.10 per share, of MoonLake AG | ||
| Phathom Pharma Inc | Asit Parikh | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.30 per share. | 19 Dec 2025 | 8,750 | 122,250 (0%) | 0% | 10.3 | 90,125 | Common Stock |
| Phathom Pharma Inc | Asit Parikh | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 8,750 | 8,750 | - | - | Common Stock (Right to Buy) | |
| Intuitive Machines Inc (Class A) | Timothy Crain | SVP and Chief Growth Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 12.06 per share. | 19 Dec 2025 | 8,741 | 439,694 | - | 12.1 | 105,440 | Class A Common Stock |
| Northpointe Bancshares Inc | Brad T. Howes | EVP, CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 8,590 | 8,590 | - | 0 | Common Stock | |
| Northpointe Bancshares Inc | Brad T. Howes | EVP, CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 8,590 | 17,180 | - | - | Restricted stock units | |
| InMed Pharma Inc | Shane Aaron Johnson | Sr VP & General Manager | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 8,500 | 12,400 | - | - | Employee Stock Option (Right to Buy) | |
| Arrowhead Pharma Inc | Christopher Anzalone | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 68.01 per share. | 19 Dec 2025 | 8,147 | 3,819,831 (3%) | 0% | 68.0 | 554,077 | Common Stock |
| Vicor Corp | Patrizio Vinciarelli | Director, Chairman and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 102.44 per share. | 19 Dec 2025 | 8,100 | 9,820,263 (34%) | 0% | 102.4 | 829,725 | Common Stock |
| USA Compression Partners LP - Unit | Christopher J. Wauson | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 8,038 | 0 | - | - | Phantom Units | |
| USA Compression Partners LP - Unit | Christopher J. Wauson | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 8,038 | 87,198 (0%) | 0% | - | Common Units | |
| Trupanion Inc | Margaret Tooth | Director, CEO | Sale of securities on an exchange or to another person at price $ 37.88 per share. | 19 Dec 2025 | 8,000 | 151,899 (0%) | 0% | 37.9 | 303,005 | Common Stock |
| Trupanion Inc | Margaret Tooth | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 8,000 | 0 | - | - | Stock Option (right to buy) | |
| Trupanion Inc | Margaret Tooth | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.93 per share. | 19 Dec 2025 | 8,000 | 159,899 (0%) | 0% | 8.9 | 71,440 | Common Stock |
| Urban Outfitters Inc | Richard A. Hayne | Director, CEO & Chairman of the Board, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 80.94 per share. | 19 Dec 2025 | 7,831 | 17,838,769 (18%) | 0% | 80.9 | 633,825 | Common Shares |
| Designer Brands Inc (Class A) | Jay L. Schottenstein | Director, Executive Chairman, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 7,673 | 83,136 | - | - | Dividend Equivalent Rights | |
| Pagaya Tech Ltd (Class A) | Tami Rosen | Director, Chief Development Officer | Sale of securities on an exchange or to another person at price $ 30.73 per share. | 19 Dec 2025 | 7,561 | 37,544 | - | 30.7 | 232,384 | Class A Ordinary Share |
| East West Bancorp Inc | Irene H. Oh | Chief Risk Officer | Sale of securities on an exchange or to another person at price $ 113.90 per share. | 19 Dec 2025 | 7,453 | 85,714 (0%) | 0% | 113.9 | 848,897 | Common Stock |
| Dayforce | Thomas M. Hagerty | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Dec 2025 | 7,300 | 75,043 (0%) | 0% | - | Common Stock | |
| Immunome Inc | Clay B. Siegall | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 20.48 per share. | 19 Dec 2025 | 7,278 | 860,525 | - | 20.5 | 149,053 | Common Stock |
| Murphy Oil Corp | R. Madison Murphy | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Dec 2025 | 7,200 | 47,332 (0%) | 0% | 0 | Common Stock | |
| Olema Pharma Inc | Naseem Zojwalla | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.02 per share. | 19 Dec 2025 | 7,182 | 153,997 | - | 7.0 | 50,418 | Common Stock |
| Olema Pharma Inc | Naseem Zojwalla | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 7,182 | 206,818 | - | - | Stock Option (Right to Buy) | |
| PotlatchDeltic Corp | Ashlee Townsend Cribb | Vice President, Wood Products | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 7,104 | 44,375 (0%) | 0% | 0 | Common Stock | |
| Capital Bancorp Inc | Kathy Yamada | EVP & Chief Credit Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 6,900 | 0 | - | - | Stock Options | |
| Capital Bancorp Inc | Kathy Yamada | EVP & Chief Credit Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.89 per share. | 19 Dec 2025 | 6,900 | 64,410 (0%) | 0% | 13.9 | 95,841 | Common Stock |
| Reddit Inc (Class A) | Jennifer L. Wong | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 234.62 per share. | 19 Dec 2025 | 6,900 | 1,195,394 | - | 234.6 | 1,618,878 | Class A Common Stock |
| Eventbrite Inc (Class A) | Julia Hartz | Director, CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 6,863 | 1,583,643 (2%) | 0% | 0 | Class A Common Stock | |
| Eventbrite Inc (Class A) | Julia Hartz | Director, CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 6,863 | 0 | - | - | Restricted Stock Units | |
| Urban Outfitters Inc | Margaret A. Hayne | Director, Co-President & CCO | Sale of securities on an exchange or to another person at price $ 80.94 per share. | 19 Dec 2025 | 6,852 | 2,274,542 (2%) | 0% | 80.9 | 554,587 | Common Shares |
| Urban Outfitters Inc | Richard A. Hayne | Director, CEO & Chairman of the Board, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 80.94 per share. | 19 Dec 2025 | 6,852 | 2,274,542 (2%) | 0% | 80.9 | 554,587 | Common Shares |
| Northpointe Bancshares Inc | Amy M. Butler | EVP, NATIONAL SALES | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.67 per share. | 19 Dec 2025 | 6,820 | 16,276 | - | 17.7 | 120,521 | Common Stock |
| Rocket Lab USA Inc | Jon A. Olson | Director | Sale of securities on an exchange or to another person at price $ 70.20 per share. | 19 Dec 2025 | 6,591 | 360,835 | - | 70.2 | 462,697 | Common Stock |
| Dollar General | Bryan D. Wheeler | EVP & Chief Merchandising Ofc | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 6,583 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Dollar General | Bryan D. Wheeler | EVP & Chief Merchandising Ofc | Exercise or conversion of derivative security received from the company (such as an option) at price $ 92.98 per share. | 19 Dec 2025 | 6,583 | 32,071 (0%) | 0% | 93.0 | 612,087 | Common Stock |
| Sinclair Inc (Class A) | Benson E. Legg | Director | Sale of securities on an exchange or to another person at price $ 15.81 per share. | 19 Dec 2025 | 6,548 | 71,165 (0%) | 0% | 15.8 | 103,524 | Class A Common Stock |
| OptimizeRx Corp | Stephen L. Silvestro | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 6,546 | 6,547 | - | - | Restricted Stock Units | |
| OptimizeRx Corp | Stephen L. Silvestro | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 6,546 | 195,462 (1%) | 0% | 0 | Common Stock | |
| USA Compression Partners LP - Unit | Christopher J. Wauson | See Remarks | Sale or transfer of securities back to the company at price $ 24.27 per share. | 19 Dec 2025 | 6,533 | 89,711 (0%) | 0% | 24.3 | 158,556 | Common Units |
| AvePoint Inc (Class A) | Xunkai Gong | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.94 per share. | 19 Dec 2025 | 6,500 | 753,177 | - | 13.9 | 90,610 | Common Stock |
| Lululemon Athletica | Martha A. Morfitt | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Dec 2025 | 6,500 | 86,990 (0%) | 0% | 0 | Common Stock | |
| PotlatchDeltic Corp | Michele L. Tyler | VP, General Counsel & Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 6,489 | 46,526 (0%) | 0% | 0 | Common Stock | |
| CCC Intelligent Soln Holdings Inc | Brian Herb | See Remarks | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Dec 2025 | 6,480 | 166,014 | - | 0 | Common Stock | |
| NVIDIA | Donald F. Robertson | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 179.36 per share. | 19 Dec 2025 | 6,400 | 442,850 (0%) | 0% | 179.4 | 1,147,873 | Common Stock |
| PotlatchDeltic Corp | Darin Robert Ball | Vice President, Timberlands | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 6,380 | 53,180 (0%) | 0% | 0 | Common Stock | |
| Joby Aviation Inc | JoeBen Bevirt | Director, CEO and Chief Architect, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Dec 2025 | 6,375 | 60,423,778 | - | 0 | Common Stock | |
| Indie Semiconductor Inc (Class A) | Naixi Wu | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 6,354 | 73,896 | - | 0 | Class A Common Stock | |
| Indie Semiconductor Inc (Class A) | Naixi Wu | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 6,354 | 6,354 | - | - | Restricted Stock Units | |
| Indie Semiconductor Inc (Class A) | Naixi Wu | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 6,354 | 0 | - | - | Restricted Stock Units | |
| Xencor Inc | John R. Desjarlais | SR. VICE PRESIDENT & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 6,311 | 5,322 | - | - | Stock Option (Right to Buy) | |
| Xencor Inc | John R. Desjarlais | SR. VICE PRESIDENT & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.51 per share. | 19 Dec 2025 | 6,311 | 242,885 (0%) | 0% | 12.5 | 78,951 | Common Stock |
| Treehouse Foods Inc | Patrick M. O’Donnell | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 6,250 | 12,500 | - | - | Restricted Stock Unit | |
| Treehouse Foods Inc | Patrick M. O’Donnell | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 6,250 | 25,814 (0%) | 0% | 0 | Common Stock | |
| Arrowhead Pharma Inc | Adeoye Y. Olukotun | Director | Sale of securities on an exchange or to another person at price $ 68.04 per share. | 19 Dec 2025 | 6,083 | 34,427 (0%) | 0% | 68.0 | 413,887 | Common Stock |
| Olema Pharma Inc | David C. Myles | CH. DISCOV. & NON-CLIN DEV OFF | Sale of securities on an exchange or to another person at price $ 31.39 per share. | 19 Dec 2025 | 6,046 | 551,881 | - | 31.4 | 189,784 | Common Stock |
| FingerMotion Inc | Yew Hon Lee | CFO | Sale of securities on an exchange or to another person at price $ 1.50 per share. | 19 Dec 2025 | 6,000 | 461,000 | - | 1.5 | 9,000 | COMMON STOCK |
| Nucor | Allen C. Behr | Executive Vice President | Sale of securities on an exchange or to another person at price $ 157.89 per share. | 19 Dec 2025 | 5,950 | 67,711 (0%) | 0% | 157.9 | 939,446 | Common Stock |
| Okta Inc (Class A) | Paul Sagan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 5,876 | 5,876 | - | - | Restricted Stock Units | |
| Okta Inc (Class A) | Robert R. Bernshteyn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 5,876 | 5,876 | - | - | Restricted Stock Units | |
| MoonLake Immunotherapeutics (Class A) | Jorge Santos da Silva | Director, Chief Executive Officer | 19 Dec 2025 | 5,836 | 0 | - | - | Common shares, par value CHF 0.10 per share, of MoonLake AG | ||
| FTI Consulting Inc | Paul Linton | CSTO and Interim CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 5,664 | 87,866 (0%) | 0% | 0 | Common Stock | |
| LiqTech Intl Inc | David Kowalczyk | CFO and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.49 per share. | 19 Dec 2025 | 5,589 | 88,779 (0%) | 0% | 1.5 | 8,328 | Common Stock |
| Clene Inc | Chidozie Ugwumba | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 6.45 per share. | 19 Dec 2025 | 5,582 | 387,568 | - | 6.5 | 36,004 | Common Stock |
| Esquire Fin Holdings Inc | Andrew C. Sagliocca | Director, Vice Chairman, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 107.00 per share. | 19 Dec 2025 | 5,530 | 264,922 (3%) | 0% | 107 | 591,710 | Common Stock |
| Arrowhead Pharma Inc | William D. Waddill | Director | Sale of securities on an exchange or to another person at price $ 68.01 per share. | 19 Dec 2025 | 5,451 | 57,063 (0%) | 0% | 68.0 | 370,723 | Common Stock |
| Jabil | Frederic E. McCoy | EVP, Global Operations | Sale of securities on an exchange or to another person at price $ 224.05 per share. | 19 Dec 2025 | 5,412 | 114,480 (0%) | 0% | 224.1 | 1,212,559 | Common Stock |
| Treehouse Foods Inc | Patrick M. O’Donnell | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 5,307 | 21,119 (0%) | 0% | 0 | Common Stock |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.